[1]
“THE ROLE OF FENOFIBRATE (TRICOR) IN THE COMPLEX TREATMENT OF MICROANGIOPATHIC COMPLICATIONS IN PATIENTS WITH TYPE 2 DIABETES”, Neo. Scie. Peer. Revi. Jour., vol. 6, pp. 20–26, Feb. 2023, Accessed: Dec. 24, 2025. [Online]. Available: https://neojournals.com/index.php/nsprj/article/view/115